James E. Flynn

Companies

• Tessera Defense & Homeland Security Inc.Board member Mar 19, 2024 to now¹
• Nuvalent, Inc.Board member Jul 28, 2021 to now²
• Zafgen (United States)Board member Jun 8, 2020 to now³
• Acutus Medical, Inc.Board member Aug 5, 2020 to Jan 28, 2025⁴
• CareMax, Inc.Board member Jul 16, 2020 to Nov 21, 2023⁵
• DA32 Life Science Tech Acquisition Corp.Board member Jul 27, 2021 to Aug 1, 2023⁶
• Silverback TherapeuticsBoard member Nov 10, 2022 to Nov 10, 2022⁷
• Oncorus, Inc.Board member Oct 1, 2020 to Feb 18, 2021⁸
• Starling Oncology, Inc.Board member Mar 10, 2020 to Mar 17, 2020⁹
• AdaptHealth Corp.Board member Feb 15, 2018 to Nov 13, 2019¹⁰
• Q32 Bio Inc.Board member Mar 27, 2018 to Jun 11, 2019¹¹
• Alpine Immune SciencesBoard member Sep 14, 2016 to Sep 14, 2016¹²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Silverback Therapeutics SPRY4,887,254 shares¹³$20.9M at $4.29Jun 27, 2025
• AMAcutus Medical, Inc.1,622,143 shares¹⁴Jan 28, 2025
• OOncorus, Inc.284,697 shares¹⁵Dec 30, 2022
• CCareMax, Inc.15,811,090 shares¹⁶Nov 21, 2023
• NNuvalent, Inc.650,000 shares¹⁷Nov 24, 2025
• DLDA32 Life Science Tech Acquisition Corp.650,000 shares¹⁸Aug 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 24, 2025Sold 371,287 shares at $95.45 of Nuvalent, Inc.¹⁷
• Nov 24, 2025Sold 371,287 shares at $95.45 of Nuvalent, Inc.¹⁷
• Jun 27, 2025Sold 370,074 shares at $18.46 of Silverback Therapeutics¹³
• Jun 27, 2025Sold 370,075 shares at $18.46 of Silverback Therapeutics¹³
• Jun 12, 2024Granted 2,499 shares of Nuvalent, Inc.¹⁹
• Jun 12, 2024Granted 2,499 shares of Nuvalent, Inc.¹⁹
• Nov 17, 2023Exercised options 12,123 shares of CareMax, Inc.¹⁶
• Jul 28, 2023Other 1,600,000 shares of DA32 Life Science Tech Acquisition Corp.¹⁸
• Jun 15, 2023Granted 8,400 shares of Acutus Medical, Inc.²⁰
• Dec 30, 2022Sold 15,220 shares at $0.27 of Oncorus, Inc.¹⁵
• Dec 30, 2022Sold 61,826 shares at $0.27 of Oncorus, Inc.¹⁵
• Dec 30, 2022Sold 61,826 shares at $0.27 of Oncorus, Inc.¹⁵
• Dec 29, 2022Sold 15,538 shares at $0.26 of Oncorus, Inc.¹⁵
• Dec 29, 2022Sold 63,108 shares at $0.26 of Oncorus, Inc.¹⁵
• Dec 29, 2022Sold 63,107 shares at $0.26 of Oncorus, Inc.¹⁵
• Dec 28, 2022Sold 6,096 shares at $0.25 of Oncorus, Inc.¹⁵
• Dec 28, 2022Sold 24,757 shares at $0.25 of Oncorus, Inc.¹⁵
• Dec 28, 2022Sold 24,757 shares at $0.25 of Oncorus, Inc.¹⁵
• Dec 21, 2022Sold 1,513 shares at $0.30 of Oncorus, Inc.²¹
• Dec 21, 2022Sold 6,143 shares at $0.30 of Oncorus, Inc.²¹
• Dec 21, 2022Sold 6,144 shares at $0.30 of Oncorus, Inc.²¹
• Dec 20, 2022Sold 1,616 shares at $0.31 of Oncorus, Inc.²¹
• Dec 20, 2022Sold 6,562 shares at $0.31 of Oncorus, Inc.²¹
• Dec 20, 2022Sold 6,562 shares at $0.31 of Oncorus, Inc.²¹
• Dec 19, 2022Sold 10,930 shares at $0.29 of Oncorus, Inc.²¹